• Tahira Mehreen
  • Nadeem Ali Shah
  • Muhammad Shahid
  • Irum Javaid
  • Munayal Roghani
  • Arslan Roghani
  • Faizan Roghani




Gastric ulceration, Gastroulcerogenesis model, Flavonoid


Background: The analgesic drugs are the main cause of gastric ulcer. The objective of this study was to determine the gastroprotective ability of flavonoid, 6-aminoflavone in a rat pyloric ligation model of aspirin associated gastro-ulcerogenesis. Methods: A laboratory based experimental study was conducted in the animal house and research laboratory at Khyber Medical College, Peshawar from July to November 2019. A total of 42 adult male Spargue-Dawely rats were divided into seven groups. Flavonoid, 6-aminoflavone was administered orally in doses of 10, 25 and 100 mg/kg with misoprostol, as standard at 50 µg/kg orally for 4 days. On the last day aspirin was given orally at 200 mg/kg and the pyloric ligation surgery was performed. After 4 hours all animals were killed by cervical dislocation. The gastric tissues were collected for histomorphological study. The obtained data were expressed as mean±SEM. Analysis was carried out by using ANOVA.  p value ˂0.05 was considered significant. Results: The animals treated with the different doses of 6-aminoflavone showed a marked protective effect in the histological observations. The 10 mg/kg dose had a mild protective effect as occasional ulcerative changes were observed. However, doses of 25 and 100 mg/kg significantly caused the reduction in the ulcer score. These effects produced were equipotent to the gastroprotective effectiveness inherent in the misoprostol. Conclusion: These findings conclude that 6-aminoflavone as like other flavonoids has a significant gastroprotective propensity with significant effect produced at doses of 25 and 100 mg/kg and can be used as a part of therapy management for the treatment of gastrointestinal disease particularly ulcerative condition.

Author Biography


Assistant Professor, Anatomy deptartment,Khyber Medical College ,Peshawar


Nalamachu S. An overview of pain management: the clinical efficacy and value of treatment. Am J Manag Care 2013;19(14 Suppl):261–6.

Drini M. Peptic ulcer disease and non-steroidal anti-inflammatory drugs. Aust Prescr 2017;40(3):91–3.

Kuna L, Jakab J, Smolic R, Raguz-Lucic N, Vcev A, Smolic M. Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options. J Clin Med 2019;8(2):179.

Melcarne L, García-Iglesias P, Calvet X. Management of NSAID-associated peptic ulcer disease. Expert Rev Gastroenterol Hopatol 2016;10(6):723–33.

Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules 2016;21(5):559.

Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 2013;1830(6):3670–95.

Jucá MM, Cysne Filho FM, de Almeida JC, Mesquita DD, Barriga JR, Dias KC, Barbosa TM, et al. Flavonoids: biological activities and therapeutic potential. Nat Prod Res 2020;34(5):692–705.

Parmar NS, Parmar S. Anti-ulcer potential of flavonoids. Indian J Physiol Pharmacol 1998;42(3):343–51.

Mota KS, Dias GE, Pinto ME, Luiz-Ferreira A, Souza-Brito AR, Hiruma-Lima CA, et al. Flavonoids with gastroprotective activity. Molecules 2009;14(3):979–1012.

Moorkoth S. Synthesis and anti-cancer activity of novel thiazolidinone analogs of 6-aminoflavone. Chem Pharm Bull (Tokyo) 2015;63(12):974–85.

Umamaheswari M, Asokkumar K, Rathidevi R, Sivashanmugam AT, Subhadradevi V, Ravi TK. Antiulcer and in vitro antioxidant activities of Jasminum grandiflorum L. J Ethnopharmacol 2007;110(3):464–70.

Imaoka H, Ishihara S, Kazumori H, Kadowaki Y, Aziz MM, Rahman FB, et al. Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice. Am J Physiol Gastrointest Liver Physiol 2010;299(2):G311–9.

Rastogi L, Patnaik GK, Dikshit M. Free radicals and antioxidant status following pylorus ligation induced gastric mucosal injury in rats. Pharmacol Res 1998;38(2):125–32.

Wagner KA, Nandi J, King RL, Levine RA. Effects of nonsteroidal antiinflammatory drugs on ulcerogenesis and gastric secretion in pylorus-ligated rat. Dig Dis Sci 1995;40(1):134–40.

Guth PH, Paulsen G. Aspirin-induced gastric injury in the rat: histologic changes and sucralfate cytoprotection. Pro Soc Exp Bio Med 1987;184(4):423–8.

Galati EM, Monforte MT, d’Aquino A, Miceli N, Di Mauro D, Sanogo R. Effects of naringin on experimental ulcer in rats. Phytomedicine 1998;5(5):361–6.

Izzo AA, Carlo GD, Mascolo N, Capasso F, Autore G. Antiulcer effect of flavonoids. Role of endogenous PAF. Phytother Res 1994;8(3):179–81.

Martin MJ, Motilva V, ÓN de la Lastra CA. Quercetin and naringenin; effects on ulcer formation and gastric secretion in rats. Phytother Res 1999;7(2):150–3.

Suarez J, Herrera MD, Marhuenda E. Hesperidin and neohesperidin dihydrochalcone on different experimental models of induced gastric ulcer. Phytother Res 1996;10(7):616–8.

Jayaraj AP, Lewin MR, Tovey FI, Kitler ME, Clark CG. The protective effect of Meciadanol (O-methyl-3 (+)-catechin) on experimental ulceration. Eur J Pharmacol 1988;147(2):265–71.